Acadia Pharma (ACAD) Balance Sheet

Click line-items for a historical chart and %

Cash and cash equivalents
Investment securities, available-for-sale
Prepaid expenses, receivables and other current assets
Total current assets
Property and equipment, net
Other assets
Total assets
Accounts payable
Accrued expenses
Current portion of deferred revenue
Current portion of long-term debt
Total current liabilities
Long-term portion of deferred revenue
Other long-term liabilities
Total liabilities
Commitments (Note 9)
Preferred stock, $0.0001 par value; 5,000,000 shares authorized at June 30, 2011 and December 31, 2010; no shares issued and outstanding at June 30, 2011 and December 31, 2010
Common stock, $0.0001 par value; 150,000,000 shares and 75,000,000 shares authorized at June 30, 2011 and December 31, 2010, respectively; 52,799,606 shares and 39,350,561 shares issued and outstanding at June 30, 2011 and December 31, 2010, respectively
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive income
Total stockholders' equity
Total liabilities and stockholders' equity

Entities mentioned with ACAD

View All Entities